Market Segmentation: France Flow Cytometry Market

ucts, the France flow cytometry market is categorized into reagents and consumables, flow cytometry instruments, accessories and services. In 2018, reagents are expected to dominate the France flow cytometry market with . The segment reagents and consumables are further sub segmented into antibodies, dyes, beads and others. The segment flow cytometry instruments are further sub segmented into cell analyzers and cell sorters. The segment services are further sub segmented into filters, laser devices, detectors and others.

Based on application France flow cytometry application market is segmented into research applications, clinical applications and industrial applications. Research application market is further sub segmented into pharmaceutical and biotechnology, immunology, apoptosis, cell sorting/ screening, cell cycle analysis, cell transfection/viability, cell counting, other research applications. Pharmaceutical and biotechnology are further segmented into drug discovery, stem cell research, in vitro toxicity testing. The clinical applications are further sub segmented into cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications.

Key Drivers: France Flow Cytometry Market

Prominent factors driving the growth of this market consists of advent of advanced technologies in flow cytometry, increased occurrences of HIV/AIDS.

Key Points: France Flow Cytometry Market

In 2017, the France flow cytometry market is dominated by BD with market share of 32.4%, followed by Merck KGaA 26.4%, Bio-Rad Laboratories Inc. 14.9%, Thermo Fisher Scientific Inc 10.2%, bioMérieux SA 5.2% and others 10.9%.